Gilead Sciences reported $25.22B in Debt for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Acorda Therapeutics ACOR:US USD 167.03M 20.66M
ALKERMES ALKS:US USD 293.27M 634K
Alnylam Pharmaceuticals ALNY:US USD 1.02B 967K
Amgen AMGN:US USD 38.94B 241M
Biogen BIIB:US USD 6.28B 1.8M
Biomarin Pharmaceutical BMRN:US USD 1.09B 3.46M
Bristol Myers Squibb BMY:US USD 39.32B 222M
Coherus Biosciences CHRS:US USD 473.67M 3.17M
GlaxoSmithKline GSK:LN GBP 20.99B 1.13B
Glaxosmithkline GSK:US GBP 20.99B 1.13B
Intercept Pharmaceuticals ICPT:US USD 332.67M 365K
Moderna Inc MRNA:US USD 1.07B 73M
Neurocrine Biosciences NBIX:US USD 169.4M 200K
Novartis NOVN:VX USD 27.91B 530M
Ptc Therapeutics PTCT:US USD 1.35B 289.13M
Puma Biotechnology PBYI:US USD 98.31M 313K
Regeneron Pharmaceuticals REGN:US USD 2.7B 300K
Sarepta Therapeutics SRPT:US USD 1.54B 1.52M
Teva Pharmaceutical Industries TEVA:US USD 21.21B 54M
United Therapeutics UTHR:US USD 800M 0
Vertex Pharmaceuticals VRTX:US USD 471.6M 29.3M
YTE INCY:US USD 33.26M 326K